Kyverna的Kyv-101在Kysa-8第2階段試驗中獲得了針對治療難治性僵人綜合症患

快訊 · 06/20 20:55

Kyverna's Kyv-101 Receives U.S. FDA Ind Clearance for Treatment of Patients With Treatment-Refractory Stiff-Person Syndrome in the Kysa-8 Phase 2 Trial

Kyverna的Kyv-101在Kysa-8第2階段試驗中獲得了針對治療難治性僵人綜合症患者的美國FDA覈准。